MedPath

A Clinical trail to see the effect of Probiotics and Docosahexaneoic Acid on learning ability, memory and behavior in Children Aged 7â??13 Years

Phase 4
Completed
Registration Number
CTRI/2016/12/007537
Lead Sponsor
Department of Health Research
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
840
Inclusion Criteria

Healthy children, aged 7â??13 years from Government/Private school who are willing to be involved in this study will be included.

Exclusion Criteria

1. Children with specific medical disorders (e.g. visual or hearing impairment), general learning difficulties will be excluded from the study.

2. Children who are eating fish > twice week and already taking Omega-3 will be excluded.

3. Children who are taking medicines expected to affect behavior and learning.

4. Children whoâ??s sibling will be in study.

5. Children with allergies to lactose will be excluded as probiotic capsule contains small amounts of lactose or skim milk product.

6. Children with weakened or compromised immune systems will be excluded.

7. Children will be excluded whose social/family circumstances would have made inclusion into the study inappropriate (e.g. serious illness in the family)

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Improvement in cognition, concentration, memory and behaviour in children aged 7-13 years. <br/ ><br>Timepoint: Baseline to Endpoint
Secondary Outcome Measures
NameTimeMethod
â?¢The study will show if effects of treatment on behaviour or cognition are mediated by change in child sleep and bowel movements? <br/ ><br>â?¢Will DHA or related fatty acids (assess objectively in blood sample) predict their learning, behaviour or sleep <br/ ><br>â?¢Are any changes in behaviour or cognitive performance associated with changes in blood fatty acid status <br/ ><br>â?¢Do sleep measures (and any changes in these) relate to objective measures of blood fatty acid status <br/ ><br> <br/ ><br>Timepoint: 0 day Baseline <br/ ><br>120 day Endpoint
© Copyright 2025. All Rights Reserved by MedPath